Alan Lotvin - 01 Apr 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP&President-PharmacyServices
Signature
/s/ Alan M. Lotvin
Issuer symbol
CVS
Transactions as of
01 Apr 2022
Net transactions value
+$4,026,718
Form type
4
Filing time
05 Apr 2022, 19:28:00 UTC
Previous filing
23 Feb 2022
Next filing
13 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Tax liability $3,854,461 -38,129 -26% $101.09 109,183 01 Apr 2022 Direct F1
holding CVS Common Stock 492 01 Apr 2022 By Children's Trusts
holding CVS Stock Unit 30,006 01 Apr 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Award $7,881,179 +77,962 $101.09 77,962 01 Apr 2022 Common Stock 77,962 $101.09 Direct F2
holding CVS Phantom Stock Credits 554 01 Apr 2022 Common Stock 554 $1.00 Direct F3, F4
holding CVS Stock Option 27,395 01 Apr 2022 Common Stock 27,395 $104.82 Direct F5
holding CVS Stock Option 32,911 01 Apr 2022 Common Stock 32,911 $78.05 Direct F6
holding CVS Stock Option 22,541 01 Apr 2022 Common Stock 22,541 $62.21 Direct F7
holding CVS Stock Option 70,702 01 Apr 2022 Common Stock 70,702 $54.19 Direct F8
holding CVS Stock Option 140,797 01 Apr 2022 Common Stock 140,797 $58.34 Direct F9, F10
holding CVS Stock Option 120,940 01 Apr 2022 Common Stock 120,940 $74.30 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Surrender of shares in payment of taxes due upon the vesting and settlement of PSUs on April 1, 2022.
F2 Option becomes exercisable in four equal installments, commencing 4/1/2023.
F3 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F4 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F5 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F6 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F7 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F8 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F9 The number of shares subject to the option were calculated using a 30-day average price.
F10 Option became exercisable in four equal annual installments, commencing 4/1/2021.
F11 Option becomes exercisable in four equal annual installments, commencing 4/1/2022.